Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

1.7K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.7K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

972
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
972
Lineage Commitment01:21

Lineage Commitment

3.0K
Commitment is the  process whereby stem cells:
3.0K
Development of Immunocompetence01:22

Development of Immunocompetence

298
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
298
Disorders of Leukocytes01:27

Disorders of Leukocytes

924
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
924

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Outcomes of Germline Testing for Children with Hematologic Malignancies Undergoing Hematopoietic Cell Transplantation.

Blood advances·2026
Same author

Prevalence and Clinical Significance of Adult-Onset Cancer Predisposition Variants in Pediatric Oncology.

medRxiv : the preprint server for health sciences·2026
Same author

HLHRUXO: A prospective trial of a ruxolitinib-containing regimen for children with hemophagocytic lymphohistiocytosis.

Blood advances·2026
Same author

Characterization of Genetic Etiologic Factors for Pediatric Acute Lymphoblastic Leukemia in Large Childhood Cancer Survivorship Cohorts.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2026
Same author

Parental Knowledge and Decisional Satisfaction Across Genomic Sequencing Consent Processes in Pediatric Cancer.

JCO oncology practice·2026
Same author

Multimodal Cytogenetic and Molecular Approach for the Detection of a Constitutional Balanced Paracentric Inversion Disrupting RB1 in an Infant With Bilateral Retinoblastoma.

Genes, chromosomes & cancer·2026

Related Experiment Video

Updated: Jun 19, 2025

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

18.0K

Childhood B cell leukemia: Intercepting the paths to progression.

Cesar Cobaleda1, Carolina Vicente-Dueñas2, Kim E Nichols3

  • 1Immune System Development and Function Unit, Centro de Biología Molecular Severo Ochoa (CBM, CSIC-UAM), Madrid, Spain.

Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology
|July 26, 2024
PubMed
Summary

Childhood B-cell Acute Lymphoblastic Leukemia (B-ALL) may stem from immune system disruptions in early life, possibly due to infections. Understanding B-ALL origins is key to developing effective prevention strategies for this common childhood cancer.

Keywords:
acutechildhooddelay‐exposuregenetic susceptibilityinfectionleukemiamurine modelspreleukemic cells

More Related Videos

Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.0K
Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

15.6K

Related Experiment Videos

Last Updated: Jun 19, 2025

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood
14:06

Isolation of Precursor B-cell Subsets from Umbilical Cord Blood

Published on: April 16, 2013

18.0K
Modeling Chemotherapy Resistant Leukemia In Vitro
08:41

Modeling Chemotherapy Resistant Leukemia In Vitro

Published on: February 9, 2016

9.0K
Flow Cytometric Characterization of Murine B Cell Development
08:25

Flow Cytometric Characterization of Murine B Cell Development

Published on: January 22, 2021

15.6K

Area of Science:

  • Pediatric Oncology
  • Immunology
  • Cancer Etiology

Background:

  • B-cell Acute Lymphoblastic Leukemia (B-ALL) is the most frequent pediatric cancer, predominantly affecting children aged 2-5 years.
  • The unique age distribution suggests a link between B-ALL development and immune system maturation during childhood, potentially influenced by early infections.
  • Despite high cure rates in developed countries, treatment side effects significantly impact survivors' quality of life.

Purpose of the Study:

  • To provide a comprehensive overview of the current understanding of childhood B-cell Acute Lymphoblastic Leukemia etiology.
  • To explore how etiological insights can guide the development of preventive strategies for B-ALL.
  • To address the substantial health burden associated with childhood B-ALL.

Main Methods:

  • Literature review of existing research on B-ALL etiology.
  • Analysis of epidemiological data concerning B-ALL incidence and age distribution.
  • Synthesis of current knowledge on immune system development and its potential role in B-ALL pathogenesis.

Main Results:

  • The article synthesizes current evidence linking early-life immune dysregulation and infection exposure to B-ALL development.
  • It highlights the critical window of susceptibility during early childhood for B-ALL onset.
  • The review underscores the need for further research into specific etiological factors.

Conclusions:

  • Understanding the origins of B-ALL is crucial for developing targeted preventive interventions.
  • Preventing childhood B-ALL could significantly reduce long-term health burdens for survivors.
  • Further investigation into the interplay between genetics, environment, and the immune system is warranted for effective B-ALL prevention.